Brookfield, CDPQ eye $1.4bn Antylia Scientific deal
Brookfield Asset Management’s private equity arm and Caisse de dépôt et placement du Québec (CDPQ) are in advanced discussions to acquire Antylia Scientific from private equity firm GTCR, according to a report by Bloomberg citing sources familiar with the matter.

